- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 28 Oct 24 424B3 Prospectus supplement
- 21 Oct 24 424B3 Prospectus supplement
- 26 Sep 24 424B3 Prospectus supplement
- 10 Sep 24 424B3 Prospectus supplement
- 24 Jul 24 424B3 Prospectus supplement
- 14 Jun 24 424B3 Prospectus supplement
- 15 May 24 424B3 Prospectus supplement
- 25 Apr 24 424B3 Prospectus supplement
- 11 Mar 24 424B3 Prospectus supplement
- 6 Mar 24 EFFECT Notice of effectiveness
- 5 Mar 24 424B3 Prospectus supplement
- 26 Feb 24 S-1/A IPO registration (amended)
- 15 Dec 23 S-1/A IPO registration (amended)
-
21 Nov 23 S-1 IPO registration
Exhibit 23.2
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of enGene Holding Inc. on Form S-1 of our report dated March 30, 2023, which includes an explanatory paragraph as to Forbion European Acquisition Corp.’s ability to continue as a going concern, with respect to our audits of the financial statements of Forbion European Acquisition Corp. as of December 31, 2022 and 2021 and for the year ended December 31, 2022 and for the period from August 9, 2021 (inception) through December 31, 2021, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum LLP
Marcum LLP
New York, NY
November 21, 2023